AERIE PHARMACEUTICALS INC
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | |
|---|---|---|---|---|---|---|
| Revenue | $194.1M | $20.3M | $10.9M | $24.2M | $0 | $0 |
| Operating income | −$46.4M | −$155.7M | −$187.5M | −$209.7M | −$145.7M | −$96.9M |
| Net income | −$74.8M | −$49.1M | −$48.0M | −$232.6M | −$145.1M | −$99.1M |
| Total assets | $431.4M | $402.0M | $452.6M | $285.0M | $290.3M | $248.3M |
| Total liabilities | $448.7M | $378.1M | $285.7M | $57.2M | $154.7M | $142.9M |
| Equity | −$17.3M | $24.0M | $166.9M | $227.8M | $135.6M | $105.3M |
| EPS (diluted) | $-1.61 | $-3.99 | $-4.39 | — | — | — |
| Shares out. | 46.9M | 46.4M | 45.9M | 39.5M | 33.6M | 26.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2021- Operating margin
- −23.9%
- Net margin
- −38.5%
- Return on equity
- 431.6%
- Return on assets
- −17.3%
- Return on capital (ROCE)
- −15.1%
- Liabilities / assets
- 104.0%
- Debt / equity
- —
- Book value / share
- $-0.37
- Revenue growth (YoY)
- 854.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2021- Altman Z″ (distress)
- -5.98distress
- Accruals / assets
- 5.6%moderate
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsNov 21, 2022
- Shareholder voteNov 18, 2022
- Other material eventNov 7, 2022
- Results of operations · Regulation FD disclosureNov 3, 2022
- Regulation FD disclosureSep 13, 2022
- Entered a material agreementAug 23, 2022
- Regulation FD disclosureAug 23, 2022
- Results of operationsAug 5, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 10, 2023
- 15-12GDec 1, 2022
- 4FORM 4 SUBMISSIONNov 21, 2022
- 4FORM 4 SUBMISSIONNov 21, 2022
- 4FORM 4 SUBMISSIONNov 21, 2022
- 4FORM 4 SUBMISSIONNov 21, 2022
- 4FORM 4 SUBMISSIONNov 21, 2022
- 4FORM 4 SUBMISSIONNov 21, 2022
- 4FORM 4 SUBMISSIONNov 21, 2022
- 4FORM 4 SUBMISSIONNov 21, 2022
- 4FORM 4 SUBMISSIONNov 21, 2022
- 4FORM 4 SUBMISSIONNov 21, 2022
- 4FORM 4 SUBMISSIONNov 21, 2022
- S-8 POSNov 21, 2022
- S-8 POSNov 21, 2022
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.